Racial differences in primary central nervous system lymphoma incidence and survival rates

Neuro-Oncology

Volumn 11, Issue 3, 2009, Pages 318-322

  Pulido, Jose S ^a,d   Vierkant, Robert A ^a   Olson, Janet E ^a   Abrey, Lauren ^b   Schiff, David ^c   O'Neill, Brian Patrick ^a  

^a MAYO CLINIC CANCER CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d MAYO CLINIC   (United States)

Author keywords

Epidemiology; Race

Indexed keywords

ADULT; AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; ASIAN AMERICAN; CALCULATION; CANCER INCIDENCE; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; ETHNIC DIFFERENCE; EUROPEAN AMERICAN; FEMALE; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PACIFIC ISLANDER; RACE DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AFRICAN AMERICANS; AFRICAN CONTINENTAL ANCESTRY GROUP; ASIAN CONTINENTAL ANCESTRY GROUP; CENTRAL NERVOUS SYSTEM NEOPLASMS; CONTINENTAL POPULATION GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; INDIANS, NORTH AMERICAN; INUITS; LYMPHOMA; MALE; MIDDLE AGED; SEER PROGRAM; SURVIVAL RATE;

EID: 67649583234     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1215/15228517-2008-103     Document Type: Article

References (21)

1. O'Neill BP. Epidemiology of primary CNS lymphoma. In: Batchelor TT, ed. Lymphoma of the Nervous System. Boston: Butterworth-Heinemann; 2004.
2. Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer. 2002;95:1504-1510.
3. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer. 2002;94:2015-2023. (Pubitemid 34270055)
4. National Cancer Institute. Surveillance, Epidemiology and End Results (SEER) Program. Available at www.seer.cancer.gov.
5. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the U.S. Cancer. 1988;62:2461-2465. (Pubitemid 18270106)
6. Schiff D, O'Neill BP. Principles of Neuro-Oncology. New York: McGraw-Hill; 2005.
7. Hader SL, Smith DK, Moore JS, Holmberg SD. HIV infection in women in the United States: status at the millennium. JAMA 2001;285:1186-1192. (Pubitemid 32198485)
8. Biggar RJ, Chaturvedi AK, Goedert JJ, Engels EA. AIDS-related cancer and severity of immunosuppression in persons with AIDS. J Natl Cancer Inst. 2007;99:962-972. (Pubitemid 47073502)
9. Romero EG, Teplin LA, McClelland GM, Abram KM, Welty LJ, Washburn JJ. A longitudinal study of the prevalence, development, and persistence of HIV/sexually transmitted infection risk behaviors in delinquent youth: implications for health care in the community. Pediatrics. 2007;119:1126-1141. (Pubitemid 46715651)
10. CDC. Cases of HIV infection and AIDS in the United States. HIV AIDS Surveill Rep. 2004;16:1-46.
11. Morris M, Handcock MS, Miller WC, et al. Prevalence of HIV infection among young adults in the United States: results from the Add Health study. Am J Public Health. 2006;96:1091-1097. (Pubitemid 43825280)
12. CDC. Cases of HIV infection and AIDS in the United States by race/ethnicity, 2000-2004. HIV AIDS Surveill Rep. 2006;12:1-36.
13. Anderson RN, Smith BL. Deaths: leading causes for 2002. Natl Vital Stat Rep. 2005;53:1-89.
14. Diamond C, Taylor TH, Im T, Wallace M, Saven A, Anton-Culver H. How valid is using cancer registries' data to identify acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma? Cancer Causes Control. 2007;18:135-142. (Pubitemid 46215310)
15. Schiff D, Suman VJ, Yang P, Rocca WA, O'Neill BP. Risk factors for primary central nervous system lymphoma: a case-control study. Cancer. 1998;82:975-982. (Pubitemid 28104180)
16. Abou-Jawde RM, Baz R, Walker E, et al. The role of race, socioeconomic status, and distance traveled on the outcome of African-American patients with multiple myeloma. Haematologica. 2006;91:1410-1413. (Pubitemid 44569819)
17. Modiano MR, Villar-Werstler P, Crowley J, Salmon SE. Evaluation of race as a prognostic factor in multiple myeloma. An ancillary of Southwest Oncology Group Study 8229. J Clin Oncol. 1996;14:974-977. (Pubitemid 26085545)
18. Bessell EM, Hoang-Xuan K, Ferreri AJ, Reni M. Primary central nervous system lymphoma: biological aspects and controversies in management. Eur J Cancer. 2007;43:1141-1152. (Pubitemid 46590731)
19. Woods LM, Rachet B, Coleman MP. Origins of socio-economic inequalities in cancer survival: a review. Ann Oncol. 2006;17:5-19. (Pubitemid 43033834)
20. Cartwright RA, Watkins G. Epidemiology of Hodgkin's disease: a review. Hematol Oncol. 2004;22:11-26. (Pubitemid 38724548)
21. Yamamoto JF, Goodman MT. Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control. 2008;19:379-390.